Target intelligence / Profile preview

Mitochondrial reactive oxygen species-generating machinery (mROS machinery)

Target
mROS machinery
Molecular classification
Enzyme complex, Oxidoreductase, Mitochondrial respiratory chain
01

Overview

The mitochondrial reactive oxygen species (ROS)-generating machinery is a complex system primarily comprising the electron transport chain (ETC) complexes, notably Complex I (NADH:ubiquinone oxidoreductase) and Complex III (ubiquinol:cytochrome c oxidoreductase), which are the principal sites of superoxide production (PMID: 28213294). Under normal physiological conditions, these ROS act as vital signaling molecules for cellular processes such as differentiation and adaptation to stress; however, their dysregulation leads to oxidative stress, causing damage to mitochondrial DNA, proteins, and lipids (PMID: 24561009). This oxidative damage is a key driver in the progression of various diseases, including neurodegenerative disorders like Parkinson's and Alzheimer's, cardiovascular diseases, and metabolic syndromes (PMID: 25644350). Therapeutic interventions targeting this machinery include mitochondria-targeted antioxidants like MitoQ and SkQ1, which are designed to accumulate in the mitochondrial matrix and neutralize ROS at their source, as well as compounds like elamipretide that stabilize mitochondrial membranes (PMID: 21030111). While promising, targeting this system requires precision to avoid inhibiting essential energy production and physiological redox signaling, which can result in mitochondrial toxicity (PMID: 28213294).

Other names
Mitochondrial electron transport chainMitochondrial respiratory chainmROS machineryMitochondrial superoxide-generating system
02

Mechanism of action

Mitochondria-targeted antioxidant scavenging of superoxide, modulation of electron transport chain activity to reduce electron leakage, and stabilization of mitochondrial membrane lipids like cardiolipin.

03

Biological functions

Energy metabolismRedox signalingApoptosisCellular homeostasis
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerDiabetes mellitusAging
05

Safety considerations

Mitochondrial toxicityInhibition of ATP synthesisLactic acidosisDisruption of physiological redox signaling
06

Interacting drugs

MitoQ

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Mitochondrial membrane potential (ΔΨm)MitoSOX fluorescenceProtein carbonyls

Beyond the preview

Go deeper on Mitochondrial reactive oxygen species-generating machinery (mROS machinery).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial reactive oxygen species-generating machinery (mROS machinery).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call